Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial.

Patel, Parind B

Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial. [electronic resource] - Intensive care medicine 04 2020 - 747-755 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial

1432-1238

10.1007/s00134-019-05913-6 doi


Adult
Analgesics, Opioid--adverse effects
Constipation--chemically induced
Critical Care
Humans
Naltrexone--analogs & derivatives
Opioid-Induced Constipation
Quaternary Ammonium Compounds